You have 9 free searches left this month | for more free features.

City

Jinan (1)

Condition

Non-small Cell Lung Cancer (NSCLC) (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

Sponsor

Jinming Yu (1)

Collaborator

Intervention

iruplinalkib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Observational (1)

iruplinalkib

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Iruplinalkib in Treatment of ALK-Positive Non-Small Cell Lung

Recruiting

Non-small Cell Lung Cancer (NSCLC)

Iruplinalkib

Jinan, Shandong, China

Shandong Cancer Hospital and Institute

Aug 8, 2023